Stock listing
Eloxx Pharmaceuticals, Inc.
Selected listing: ELOX · OTC · USD · US
Eloxx Pharmaceuticals, Inc. (OTC:ELOX), Health Technology. Latest release Sep 14, 2026: Eloxx Pharmaceuticals Announces First Patients Dosed in Phase 2b EXACT…
- Ticker
- OTC:ELOX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- OTC
- Currency
- USD
About Eloxx Pharmaceuticals, Inc.
Eloxx Pharmaceuticals, Inc. is a public company traded under the ticker ELOX in the American market. Eloxx focuses on developing therapies for genetic diseases caused by nonsense mutations.
Latest news from Eloxx Pharmaceuticals, Inc.
Eloxx Pharmaceuticals Announces First Patients Dosed in Phase 2b EXACT Study of Exaluren in Nonsense Mutation Alport Syndrome
September 14, 2026
Eloxx Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
August 12, 2026
Eloxx Pharmaceuticals Announces Key Corporate Accomplishments
November 12, 2024
Eloxx Pharmaceuticals Provides Pipeline and Financing Updates
July 11, 2024
Eloxx Pharmaceuticals Provides ELX-02 and ZKN-013 Program Updates
April 16, 2024
Events
Replays
Eloxx Pharmaceuticals, Inc. (ELOX) Q4 2020 Earnings Call
Thu, Mar 11, 2021 · 04:30 PM ET
Watch
Research Eloxx Pharmaceuticals, Inc.
Eloxx Pharmaceuticals, Inc. company profile
View the public company page for Eloxx Pharmaceuticals, Inc. on 6ix.
Eloxx Pharmaceuticals, Inc. news
Read company news and market updates connected to Eloxx Pharmaceuticals, Inc..
Eloxx Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Eloxx Pharmaceuticals, Inc..